KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 118 filers reported holding KRYSTAL BIOTECH INC in Q1 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,000 | +93.7% | 10,000 | +96.1% | 0.00% | – |
| Q2 2023 | $598,740 | +33016.2% | 5,100 | -77.7% | 0.00% | -100.0% |
| Q4 2022 | $1,808 | -99.7% | 22,823 | +128.2% | 0.00% | – |
| Q3 2022 | $697,000 | -83.9% | 10,000 | -84.9% | 0.00% | -100.0% |
| Q2 2022 | $4,339,000 | +552.5% | 66,076 | +560.8% | 0.00% | – |
| Q1 2022 | $665,000 | -84.5% | 10,000 | -83.7% | 0.00% | -100.0% |
| Q4 2021 | $4,297,000 | +231.8% | 61,429 | +147.6% | 0.00% | +100.0% |
| Q3 2021 | $1,295,000 | +494.0% | 24,810 | +675.3% | 0.00% | – |
| Q2 2021 | $218,000 | -92.7% | 3,200 | -91.7% | 0.00% | -100.0% |
| Q1 2021 | $2,973,000 | +29.2% | 38,600 | +0.7% | 0.00% | +50.0% |
| Q4 2020 | $2,301,000 | +433.9% | 38,344 | +283.4% | 0.00% | +100.0% |
| Q3 2020 | $431,000 | +49.7% | 10,000 | +43.6% | 0.00% | – |
| Q2 2020 | $288,000 | -40.5% | 6,964 | -50.1% | 0.00% | -100.0% |
| Q3 2019 | $484,000 | -90.0% | 13,954 | -88.4% | 0.00% | -85.7% |
| Q2 2019 | $4,830,000 | +64.7% | 119,929 | +34.5% | 0.01% | +75.0% |
| Q1 2019 | $2,933,000 | +665.8% | 89,155 | +246.0% | 0.00% | – |
| Q2 2018 | $383,000 | +120.1% | 25,764 | +49.8% | 0.00% | – |
| Q1 2018 | $174,000 | -34.6% | 17,198 | -31.9% | 0.00% | – |
| Q4 2017 | $266,000 | – | 25,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |